Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
Non-communicable diseases (NCDs), represented by cardiovascular diseases and cancer, have been the leading cause of death globally. Improvements in mortality from cardiovascular (CV) diseases (decrease of 14%/100,000, United States) or cancers (increase 7.5%/100,000, United States) seem unsatisfacto...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.879351/full |
| _version_ | 1811240351275417600 |
|---|---|
| author | Qianru Leng Jie Ding Meiyan Dai Lei Liu Qing Fang Dao Wen Wang Lujin Wu Yan Wang |
| author_facet | Qianru Leng Jie Ding Meiyan Dai Lei Liu Qing Fang Dao Wen Wang Lujin Wu Yan Wang |
| author_sort | Qianru Leng |
| collection | DOAJ |
| description | Non-communicable diseases (NCDs), represented by cardiovascular diseases and cancer, have been the leading cause of death globally. Improvements in mortality from cardiovascular (CV) diseases (decrease of 14%/100,000, United States) or cancers (increase 7.5%/100,000, United States) seem unsatisfactory during the past two decades, and so the search for innovative and accurate biomarkers of early diagnosis and prevention, and novel treatment strategies is a valuable clinical and economic endeavor. Both tumors and cardiovascular system are rich in angiological systems that maintain material exchange, signal transduction and distant regulation. This pattern determines that they are strongly influenced by circulating substances, such as glycolipid metabolism, inflammatory homeostasis and cyclic non-coding RNA and so forth. Platelets, a group of small anucleated cells, inherit many mature proteins, mRNAs, and non-coding RNAs from their parent megakaryocytes during gradual formation and manifest important roles in inflammation, angiogenesis, atherosclerosis, stroke, myocardial infarction, diabetes, cancer, and many other diseases apart from its classical function in hemostasis. MicroRNAs (miRNAs) are a class of non-coding RNAs containing ∼22 nucleotides that participate in many key cellular processes by pairing with mRNAs at partially complementary binding sites for post-transcriptional regulation of gene expression. Platelets contain fully functional miRNA processors in their microvesicles and are able to transport their miRNAs to neighboring cells and regulate their gene expression. Therefore, the importance of platelet-derived miRNAs for the human health is of increasing interest. Here, we will elaborate systematically the roles of platelet-derived miRNAs in cardiovascular disease and cancer in the hope of providing clinicians with new ideas for early diagnosis and therapeutic strategies. |
| first_indexed | 2024-04-12T13:17:28Z |
| format | Article |
| id | doaj.art-7c76b7acfdf445239992b2b36917cb5b |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-04-12T13:17:28Z |
| publishDate | 2022-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-7c76b7acfdf445239992b2b36917cb5b2022-12-22T03:31:38ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-06-01910.3389/fcvm.2022.879351879351Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic TargetQianru LengJie DingMeiyan DaiLei LiuQing FangDao Wen WangLujin WuYan WangNon-communicable diseases (NCDs), represented by cardiovascular diseases and cancer, have been the leading cause of death globally. Improvements in mortality from cardiovascular (CV) diseases (decrease of 14%/100,000, United States) or cancers (increase 7.5%/100,000, United States) seem unsatisfactory during the past two decades, and so the search for innovative and accurate biomarkers of early diagnosis and prevention, and novel treatment strategies is a valuable clinical and economic endeavor. Both tumors and cardiovascular system are rich in angiological systems that maintain material exchange, signal transduction and distant regulation. This pattern determines that they are strongly influenced by circulating substances, such as glycolipid metabolism, inflammatory homeostasis and cyclic non-coding RNA and so forth. Platelets, a group of small anucleated cells, inherit many mature proteins, mRNAs, and non-coding RNAs from their parent megakaryocytes during gradual formation and manifest important roles in inflammation, angiogenesis, atherosclerosis, stroke, myocardial infarction, diabetes, cancer, and many other diseases apart from its classical function in hemostasis. MicroRNAs (miRNAs) are a class of non-coding RNAs containing ∼22 nucleotides that participate in many key cellular processes by pairing with mRNAs at partially complementary binding sites for post-transcriptional regulation of gene expression. Platelets contain fully functional miRNA processors in their microvesicles and are able to transport their miRNAs to neighboring cells and regulate their gene expression. Therefore, the importance of platelet-derived miRNAs for the human health is of increasing interest. Here, we will elaborate systematically the roles of platelet-derived miRNAs in cardiovascular disease and cancer in the hope of providing clinicians with new ideas for early diagnosis and therapeutic strategies.https://www.frontiersin.org/articles/10.3389/fcvm.2022.879351/fullplateletMicroRNAscardiovascular diseasescancerplatelet-derived microvesicle (PMV) |
| spellingShingle | Qianru Leng Jie Ding Meiyan Dai Lei Liu Qing Fang Dao Wen Wang Lujin Wu Yan Wang Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target Frontiers in Cardiovascular Medicine platelet MicroRNAs cardiovascular diseases cancer platelet-derived microvesicle (PMV) |
| title | Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target |
| title_full | Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target |
| title_fullStr | Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target |
| title_full_unstemmed | Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target |
| title_short | Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target |
| title_sort | insights into platelet derived micrornas in cardiovascular and oncologic diseases potential predictor and therapeutic target |
| topic | platelet MicroRNAs cardiovascular diseases cancer platelet-derived microvesicle (PMV) |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2022.879351/full |
| work_keys_str_mv | AT qianruleng insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT jieding insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT meiyandai insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT leiliu insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT qingfang insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT daowenwang insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT lujinwu insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget AT yanwang insightsintoplateletderivedmicrornasincardiovascularandoncologicdiseasespotentialpredictorandtherapeutictarget |